Dexamethasone differentially regulates functional membrane properties in glioma cell lines and primary astrocytes in vitro

Journal of Neuro-Oncology

Volumn 103, Issue 3, 2011, Pages 479-489

  Hinkerohe, Daniel ^a   Wolfkühler, Dörte ^b   Haghikia, Aiden ^c   Meier, Carola ^b   Faustmann, Pedro M ^b   Schlegel, Uwe ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c ST JOSEF HOSPITAL   (Germany)

Author keywords

Astroglia; Connexin 43; Dexamethasone; Glioma; Microglia

Indexed keywords

CONNEXIN 43; DEXAMETHASONE;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL JUNCTION; CELL MEMBRANE STEADY POTENTIAL; COCULTURE; CONTROLLED STUDY; GLIOMA CELL; HUMAN; HUMAN CELL; MEMBRANE DEPOLARIZATION; NONHUMAN; PROTEIN EXPRESSION; RAT;

ANIMALS; ANIMALS, NEWBORN; ANTINEOPLASTIC AGENTS, HORMONAL; ASTROCYTES; BRAIN NEOPLASMS; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CONNEXIN 43; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ECTODYSPLASINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HORMONE ANTAGONISTS; HUMANS; MEMBRANE POTENTIALS; MIFEPRISTONE; PATCH-CLAMP TECHNIQUES; RATS; RATS, WISTAR; STATISTICS, NONPARAMETRIC;

EID: 79959807596     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0456-6     Document Type: Article

References (58)

1. Lin JH, Takano T, Cotrina ML, Arcuino G, Kang J, Liu S, Gao Q, Jiang L, Li F, Lichtenberg-Frate H, Haubrich S, Willecke K, Goldman SA, Nedergaard M (2002) Connexin 43 enhances the adhesivity and mediates the invasion of malignant glioma cells. J Neurosci 22:4302-4311 (Pubitemid 37465645)
2. Giaume C, McCarthy KD (1996) Control of gap-junctional communication in astrocytic networks. Trends Neurosci 19:319-325 (Pubitemid 26349060)
3. Bruzzone R, White TW, Paul DL (1996) Connections with connexins: the molecular basis of direct intercellular signaling. Eur J Biochem 238:1-27 (Pubitemid 26164180)
4. Dermietzel R, Hertberg EL, Kessler JA, Spray DC (1991) Gap junctions between cultured astrocytes: immunocytochemical, molecular, and electrophysiological analysis. J Neurosci 11:1421-1432
5. Retamal MA, Froger N, Palacios-Prado N, Ezan P, Saez PJ, Saez JC, Giaume C (2007) Cx43 hemichannels and gap junction channels in astrocytes are regulated oppositely by proinflammatory cytokines released from activated microglia. J Neurosci 27:13781-13792 (Pubitemid 350278255)
6. Meme W, Calvo CF, Froger N, Ezan P, Amigou E, Koulakoff A, Giaume C (2006) Proinflammatory cytokines released from microglia inhibit gap junctions in astrocytes: potentiation by beta-amyloid. Fed Am Soc Exp Biol J 20:494-496 (Pubitemid 46671227)
7. Theis M, Speidel D, Willecke K (2004) Astrocyte cultures from conditional connexin43-deficient mice. Glia 46:130-141 (Pubitemid 38596179)
8. Rouach N, Calvo CF, Glowinski J, Giaume C (2002) Brain macrophages inhibit gap junctional communication and down-regulate connexin 43 expression in cultured astrocytes. Eur J Neurosci 15:403-407 (Pubitemid 35471963)
9. John GR, Scemes E, Suadicani SO, Liu JS, Charles PC, Lee SC, Spray DC, Brosnan CF (1999) IL-1 beta differentially regulates calcium wave propagation between primary human fetal astrocytes via pathways involving P2 receptors and gap junction channels. Proc Natl Acad Sci U S A 96:11613-11618 (Pubitemid 29487429)
10. Faustmann PM, Haase CG, Romberg S, Hinkerohe D, Szlachta D, Smikalla D, Krause D, Dermietzel R (2003) Microglia activation influences dye coupling and Cx43 expression of the astrocytic network. Glia 42:101-108 (Pubitemid 36565114)
11. Kielian T (2008) Glial connexins and gap junctions in CNS inflammation and disease. J Neurochem 106:1000-1016
12. Haghikia A, Ladage K, Hinkerohe D, Vollmar P, Heupel K, Dermietzel R, Faustmann PM (2008) Implications of antiinflammatory properties of the anticonvulsant drug levetiracetam in astrocytes. J Neurosci Res 86:1781-1788 (Pubitemid 351859428)
13. Haghikia A, Ladage K, Lafenetre P, Haghikia A, Hinkerohe D, Smikalla D, Haase CG, Dermietzel R, Faustmann PM (2008) Intracellular application of TNF-alpha impairs cell to cell communication via gap junctions in glioma cells. J Neurooncol 86:143-152 (Pubitemid 350263411)
14. Hinkerohe D, Smikalla D, Haghikia A, Heupel K, Haase CG, Dermietzel R, Faustmann PM (2005) Effects of cytokines on microglial phenotypes and astroglial coupling in an inflammatory coculture model. Glia 52:85-97 (Pubitemid 41652913)
15. Vollmar P, Haghikia A, Dermietzel R, Faustmann PM (2008) Venlafaxine exhibits an anti-inflammatory effect in an inflammatory co-culture model. Int J Neuropsychopharmacol 11:111-117
16. Das A, Banik NL, Patel SJ, Ray SK (2004) Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities. Mol Cancer 3:36
17. Weller M, Schmidt C, Roth W, Dichgans J (1997) Chemotherapy of human malignant glioma: prevention of efficacy by dexamethasone? Neurology 48:1704-1709
18. Gorman AM, Hirt UA, Orrenius S, Ceccatelli S (2000) Dexamethasone pre-treatment interferes with apoptotic death in glioma cells. Neuroscience 96:417-425 (Pubitemid 30100423)
19. Wolff JE, Jurgens H (1994) Dexamethasone induced partial resistance to methotrexate in C6-glioma cells. Anticancer Res 14:1585-1588 (Pubitemid 24354210)
20. Robe PA, Nguyen-Khac M, Jolois O, Rogister B, Merville MP, Bours V (2005) Dexamethasone inhibits the HSV-tk/ganciclovir bystander effect in malignant glioma cells. BMC Cancer 5:32
21. Fleige G, Nolte C, Synowitz M, Seeberger F, Kettenmann H, Zimmer C (2001) Magnetic labeling of activated microglia in experimental gliomas. Neoplasia 3:489-499 (Pubitemid 33151015)
22. Badie B, Schartner J (2001) Role of microglia in glioma biology. Microsc Res Tech 54:106-113 (Pubitemid 32645875)
23. Watters JJ, Schartner JM, Badie B (2005) Microglia function in brain tumors. J Neurosci Res 81:447-455 (Pubitemid 41359299)
24. Slepko N, Levi G (1996) Progressive activation of adult microglial cells in vitro. Glia 16:241-246 (Pubitemid 26309466)
25. Nestler U, Winking M, Boker DK (2002) The tissue level of dexamethasone in human brain tumors is about 1000 times lower than the cytotoxic concentration in cell culture. Neurol Res 24:479-482 (Pubitemid 34742682)
26. Hofer A, Saez JC, Chang CC, Trosko JE, Spray DC, Dermietzel R (1996) C-erbB2/neu transfection induces gap junctional communication incompetence in glial cells. J Neurosci 16:4311-4321 (Pubitemid 26243027)
27. Aschner M, Sonnewald U, Tan KH (2002) Astrocyte modulation of neurotoxic injury. Brain Pathol 12:475-481 (Pubitemid 35154935)
28. Dermietzel R, Spray DC (1998) From neuro-glue ('Nervenkitt') to glia: a prologue. Glia 24:1-7 (Pubitemid 28370207)
29. Martyn KD, Kurata WE, Warn-Cramer BJ, Burt JM, TenBroek E, Lau AF (1997) Immortalized connexin43 knockout cell lines display a subset of biological properties associated with the transformed phenotype. Cell Growth Differ 8:1015-1027 (Pubitemid 27388097)
30. Huang RP, Fan Y, Hossain MZ, Peng A, Zeng ZL, Boynton AL (1998) Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43 (cx43). Cancer Res 58:5089-5096 (Pubitemid 28521167)
31. Soroceanu L, Manning TJ Jr, Sontheimer H (2001) Reduced expression of connexin-43 and functional gap junction coupling in human gliomas. Glia 33:107-117 (Pubitemid 32160974)
32. Ruch RJ (1994) The role of gap junctional intercellular communication in neoplasia. Ann Clin Lab Sci 24:216-231
33. Moolten FL (1986) Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 46:5276-5281
34. Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM (1992) In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256:1550-1552
35. Mesnil M, Piccoli C, Tiraby G, Willecke K, Yamasaki H (1996) Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. Proc Natl Acad Sci U S A 93:1831-1835 (Pubitemid 26079840)
36. Andrade-Rozental AF, Rozental R, Hopperstad MG, Wu JK, Vrionis FD, Spray DC (2000) Gap junctions: the "kiss of death" and the "kiss of life". Brain Res Brain Res Rev 32:308-315
37. Green SB, Byar DP, Walker MD, Pistenmaa DA, Alexander E Jr, Batzdorf U, Brooks WH, Hunt WE, Mealey J Jr, Odom GL, Paoletti P, Ransohoff J 2nd, Robertson JT, Selker RG, Shapiro WR, Smith KR Jr, Wilson CB, Strike TA (1983) Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 67:121-132 (Pubitemid 13110644)
38. Wolff JE, Denecke J, Jurgens H (1996) Dexamethasone induces partial resistance to cisplatinum in C6 glioma cells. Anticancer Res 16:805-809 (Pubitemid 26182013)
39. Reuss B, Dermietzel R, Unsicker K (1998) Fibroblast growth factor 2 (FGF-2) differentially regulates connexin (cx) 43 expression and function in astroglial cells from distinct brain regions. Glia 22:19-30 (Pubitemid 28038041)
40. Bordey A, Sontheimer H (1998) Electrophysiological properties of human astrocytic tumor cells in situ: enigma of spiking glial cells. J Neurophysiol 79:2782-2793 (Pubitemid 28261657)
41. Labrakakis C, Patt S, Weydt P, Cervos-Navarro J, Meyer R, Kettenmann H (1997) Action potential-generating cells in human glioblastomas. J Neuropathol Exp Neurol 56:243-254 (Pubitemid 27461165)
42. Barres BA (1991) New roles for glia. J Neurosci 11:3685-3694
43. Kimelberg HK, Pang S, Treble DH (1989) Excitatory amino acid-stimulated uptake of 22 Na ? in primary astrocyte cultures. J Neurosci 9:1141-1149 (Pubitemid 19116736)
44. Binder DK, Steinhauser C (2006) Functional changes in astroglial cells in epilepsy. Glia 54:358-368 (Pubitemid 44422938)
45. Lampe PD, Lau AF (2000) Regulation of gap junctions by phosphorylation of connexins. Arch Biochem Biophys 384:205-215 (Pubitemid 32012794)
46. Simard M, Couldwell WT, Zhang W, Song H, Liu S, Cotrina ML, Goldman S, Nedergaard M (1999) Glucocorticoids-potent modulators of astrocytic calcium signaling. Glia 28:1-12 (Pubitemid 29475574)
47. Moller C, Haghikia A, Heupel K, Hinkerohe D, Smikalla D, Szlachta D, Dermietzel R, Faustmann PM (2005) Influences of activated microglia on the membrane resting potential and the gap junction communication of an astroglial cell line. Acta Neuropathol (Berl) 110(3):334
48. Ghosh A, Mukherjee J, Bhattacharjee M, Sarkar P, Acharya S, Chaudhuri S, Chaudhuri S (2007) The other side of the coin: beneficiary effect of 'oxidative burst' upsurge with T11TS facilitates the elimination of glioma cells. Cell Mol Biol (Noisyle-grand) 53:53-62
49. Frei K, Siepl C, Groscurth P, Bodmer S, Schwerdel C, Fontana A (1987) Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells. Eur J Immunol 17:1271-1278 (Pubitemid 17148166)
50. Tran TT, Uhl M, Ma JY, Janssen L, Sriram V, Aulwurm S, Kerr I, Lam A, Webb HK, Kapoun AM, Kizer DE, McEnroe G, Hart B, Axon J, Murphy A, Chakravarty S, Dugar S, Protter AA, Higgins LS, Wick W, Weller M, Wong DH (2007) Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model. NeuroOncology 9:259-270 (Pubitemid 47169658)
51. Leitlein J, Aulwurm S, Waltereit R, Naumann U, Wagenknecht B, Garten W, Weller M, Platten M (2001) Processing of immunosuppressive pro-TGF-beta 1, 2 by human glioblastoma cells involves cytoplasmic and secreted furin-like proteases. J Immunol 166:7238-7243 (Pubitemid 32525597)
52. Wick W, Grimmel C, Wild-Bode C, Platten M, Arpin M, Weller M (2001) Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2. J Neurosci 21:3360-3368 (Pubitemid 32422801)
53. Ossege LM, Sindern E, Voss B, Malin JP (1998) Corticosteroids induce expression of transforming-growth-factor-beta1 mRNA in peripheral blood mononuclear cells of patients with multiple sclerosis. J Neuroimmunol 84:1-6 (Pubitemid 28210443)
54. Ossege LM, Sindern E, Voss B, Malin JP (1999) Immunomodulatory effects of IFN beta-1b on the mRNA-expression of TGF beta-1 and TNF alpha in vitro. Immunopharmacology 43:39-46
55. Wick W, Naumann U, Weller M (2006) Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma. Curr Pharm Des 12:341-349
56. Hau P, Jachimczak P, Schlingensiepen R, Schulmeyer F, Jauch T, Steinbrecher A, Brawanski A, Proescholdt M, Schlaier J, Buchroithner J, Pichler J, Wurm G, Mehdorn M, Strege R, Schuierer G, Villarrubia V, Fellner F, Jansen O, Straube T, Nohria V, Goldbrunner M, Kunst M, Schmaus S, Stauder G, Bogdahn U, Schlingensiepen KH (2007) Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies. Oligonucleotides 17:201-212 (Pubitemid 47124417)
57. Schlingensiepen KH, Fischer-Blass B, Schmaus S, Ludwig S (2008) Antisense therapeutics for tumor treatment: the TGF-beta2 inhibitor AP 12009 in clinical development against malignant tumors. Recent Results Cancer Res 177:137-150
58. Zhang W, Couldwell WT, Simard MF, Song H, Lin JH, NedergaardM(1999) Direct gap junction communication between malignant glioma cells and astrocytes. Cancer Res 59:1994-2003 (Pubitemid 29186177)